NantKwest Inc.

NantKwest Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$108.54 M
Shares Outstanding
98.67 M
Public Float
9.14 M


3530 John Hopkins Court
San Diego California 92121
United States
Employees -
Updated 07/08/2019
NantKwest, Inc. engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The firm operates through the following geographical segments: United States; Europe; and Other Non-U.


View All

Patrick Soon-Shiong
Chairman & Chief Executive Officer
Barry J. Simon
President, Director & Chief Administrative Officer